National programme
- P2-0089, “Advanced magnetic and multifunctional materials” (2020–2025).
Running projects
- L2-60141 Enhancing heat exchanger performance using advanced superhydrophobic coating; Super-COR-AI, started on 1. 1. 2025.
- J2-60038 Interactions of nanoparticles with complexants from biomass: environmental fate and reuse, started on 1. 1. 2025.
- J2-60047 Magnetic micro-structuring of the Mg alloy surfaces for improved endothelialization and retained degradability of vascular stent materials, started on 1. 1. 2025.
- GC-0003, Nanostructured Hybrid Semiconducting Materials and Devices, started on 1. 10. 2024.
- BI-RS/23-25-030 (from 1. 7. 23 – 30. 6. 25): “The anisotropic iron oxide nanoparticles for medical applications: magneto-mechanical effect and hyperthermia”.
- HORIZON-MSCA-2022-DN, 01101119614 — MAESTRI: “Magnetic Soft Matter for Robotics“, started on 4. 3. 2024.
- N2-0367, Multifunctional Hybrid Materials with Controlled Ferroic Properties, started on 1. 3. 2024.
- PR-13066-6 HyBReED Development of resilient chemical energy storage by hydrogen and batteries, started on 1. 1. 2024.
- Bilateral project JSI–CNR: “Nano-driven ferroic coupling in hexaferrites – NanoFer”, started on 1. 1. 2024.
- J2-50061 Novel materials based on lignin from biomass with enhanced luminescent activity, started on 1. 10. 2023.
- N2-0324 CerAM-Heat: Additive manufacturing of porous polymer-derived ceramics with magnetic heating capability enabling an electrification of chemical processes, started on 1. 10. 2023.
- J2-50061: Novel materials based on lignin from biomass with enhanced luminescent activity, started on 1. 10. 2023.
- J1-4416 The development of a highly sensitive electrochemical method for trace determination of antibiotic compounds based on magnetic polymeric nanocomposites in environmental systems, started on 1. 10. 2022
- J7-4420: “Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles”, started on 1. 10. 2022.
- J3-3079 Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms, started on 1. 12. 2021
- J3-3079: “Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms”, started on 1. 12. 2021.
- J2-3046: “Selective electroporation by distributed nanoelectrodes“, started on 1. 10. 2021.
- J2-3043: “Exploitation of the magneto-mechanical effect in the treatment of neurodegenerative diseases“, started on 1. 10. 2021.
- J2-3040: “Magnetically-controllable nanocarriers mimicking endogenous lipid particles for improved drug/nanoparticle delivery“, started on 1. 10. 2021.
- J1-3006: “Magneto Responsive Surfaces for Manipulation of Light and Liquids” (vodja Irena Drevenšek Olenik – F7), started on 1. 10. 2021.
- 899285-MAGNELIQ-H2020-FETOPEN-2018-2020: “A Magneto-Electric Liquid – to Sense Better“, started on 1. 11. 2020.
- PASSENGER (Pilot Action for Securing a Sustainable European Next Generation of Efficient RE-free Magnets), started on 1. 5. 2021.
Past projects
- BI-FR/23-24-PROTEUS-005: “In Vitro and In Vivo magneto-mechanical destruction of tumors by anisotropic magnetic nanoparticles”, completed on 31. 12. 2024.
- 101022738-ORACLE- Research and Innovation Action-2020-2023: “Novel Routes and Catalysts for Synthesis of Ammonia as Alternative Renewable Fuel”, completed on 31. 10. 2024.
- J2-8267: “Electrically tunable ferromagnetic liquids“.
- J1-2459: “Liquid Magnets: fundamental studies of ferromagnetic order in liquids“.
- J2-2495: “Surface-selective hybridization technology for magneto-electric hybrids“. Partners: Department for Materials Synthesis and Department for Complex Matter from Jožef Stefan Institute, and Faculty of Chemistry and Chemical technology, University of Ljubljana.
- N2-0118: Seal of Excellence: “MultiJanus“
- J2-8166: “Anisotropic magnetic nanoparticles for the magneto-mechanical therapy of cancer“.
- J1-7302: “Nanotheranostics based on magneto-responsive materials”, completed on 31. 12. 2018.
- J3-7494: “Tunneling nanotubes for innovative urinary bladder cancer treatments”, completed on 31. 12. 2018.